These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19591781)

  • 41. Two-Parametric Immunological Score Development for Assessing Renal Involvement and Disease Activity in Systemic Lupus Erythematosus.
    Sjöwall C; Bentow C; Aure MA; Mahler M
    J Immunol Res; 2018; 2018():1294680. PubMed ID: 30246032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pathogenesis of systemic lupus erythematosus: Harnessing big data to understand the molecular basis of lupus.
    Catalina MD; Owen KA; Labonte AC; Grammer AC; Lipsky PE
    J Autoimmun; 2020 Jun; 110():102359. PubMed ID: 31806421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human low-affinity IgG receptor FcγRIIA polymorphism H131R associates with subclinical atherosclerosis and increased platelet activity in systemic lupus erythematosus.
    Clancy R; El Bannoudi H; Rasmussen SE; Bornkamp N; Allen N; Dann R; Reynolds H; Buyon JP; Berger JS
    J Thromb Haemost; 2019 Mar; 17(3):532-537. PubMed ID: 30638300
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of +3179G/A insulin-like growth factor-1 receptor polymorphism and insulin-like growth factor-1 serum level with systemic lupus erythematosus.
    Stanilova SA; Ivanova MG; Karakolev IA; Stoilov RM; Rashkov RK; Manolova IM
    Lupus; 2013 Nov; 22(13):1388-93. PubMed ID: 23989734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus.
    Liu CC; Manzi S; Kao AH; Navratil JS; Ruffing MJ; Ahearn JM
    Arthritis Rheum; 2005 Oct; 52(10):3087-99. PubMed ID: 16200588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mendelian randomization analysis revealed potential causal factors for systemic lupus erythematosus.
    Mo X; Guo Y; Qian Q; Fu M; Lei S; Zhang Y; Zhang H
    Immunology; 2020 Mar; 159(3):279-288. PubMed ID: 31670388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SLE: challenges and candidates in human disease.
    Croker JA; Kimberly RP
    Trends Immunol; 2005 Nov; 26(11):580-6. PubMed ID: 16168709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of MASP2 levels and MASP2 gene polymorphisms with systemic lupus erythematosus.
    Xu WD; Liu XY; Su LC; Huang AF
    J Cell Mol Med; 2020 Sep; 24(18):10432-10443. PubMed ID: 32677764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent insights into the genetic basis of systemic lupus erythematosus.
    Moser KL; Kelly JA; Lessard CJ; Harley JB
    Genes Immun; 2009 Jul; 10(5):373-9. PubMed ID: 19440199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biomarkers in systemic lupus erythematosus.
    Illei GG; Lipsky PE
    Curr Rheumatol Rep; 2004 Oct; 6(5):382-90. PubMed ID: 15355751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum and urine interleukin-17A levels as biomarkers of disease activity in systemic lupus erythematosus.
    Nordin F; Shaharir SS; Abdul Wahab A; Mustafar R; Abdul Gafor AH; Mohamed Said MS; Rajalingham S; Shah SA
    Int J Rheum Dis; 2019 Aug; 22(8):1419-1426. PubMed ID: 31179646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of Serum β2-microglobulin in Egyptian Patients with Systemic Lupus Erythematosus.
    Abd-Elbaky NM; Albeltagy ES; Hammour AE; Ibrahim AS
    Egypt J Immunol; 2019 Jul; 26(2):143-153. PubMed ID: 31926503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.
    Song LJ; Wang X; Wang XP; Li D; Ding F; Liu HX; Yu X; Li XF; Shu Q
    Diagn Pathol; 2015 Jun; 10():71. PubMed ID: 26076826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus.
    Wu GC; Li J; Leng RX; Li XP; Li XM; Wang DG; Pan HF; Ye DQ
    Oncotarget; 2017 Apr; 8(14):23650-23663. PubMed ID: 28423570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
    Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association Between C1q, TRAIL, and Tim-1 Gene Polymorphisms and Systemic Lupus Erythematosus.
    Yu Y; Zhu C; Zhou S; Chi S
    Genet Test Mol Biomarkers; 2018 Sep; 22(9):546-553. PubMed ID: 30183357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigation of C1-complex regions reveals new C1Q variants associated with protection from systemic lupus erythematosus, and affect its transcript abundance.
    Guo J; Gao Y; Wang Y; Zou Y; Du Y; Luo C; Shi Y; Yang Y; Wu X; Su Y; Wu L; Chen S; Li Z
    Sci Rep; 2018 May; 8(1):8048. PubMed ID: 29795138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet C4d is highly specific for systemic lupus erythematosus.
    Navratil JS; Manzi S; Kao AH; Krishnaswami S; Liu CC; Ruffing MJ; Shaw PS; Nilson AC; Dryden ER; Johnson JJ; Ahearn JM
    Arthritis Rheum; 2006 Feb; 54(2):670-4. PubMed ID: 16447243
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell-bound complement activation products (CB-CAPs) have high sensitivity and specificity in pediatric-onset systemic lupus erythematosus and correlate with disease activity.
    Hui-Yuen JS; Gartshteyn Y; Ma M; O'Malley T; Conklin J; Eichenfield AH; Imundo LF; Dervieux T; Askanase AD
    Lupus; 2018 Dec; 27(14):2262-2268. PubMed ID: 30376789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.